Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.795 USD | -0.83% |
|
-4.74% | -9.53% |
05-14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
05-13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.53% | 31.45M | |
+16.51% | 82.53B | |
-26.86% | 73B | |
-1.13% | 26.4B | |
-11.07% | 17.12B | |
+0.68% | 17.09B | |
-0.56% | 15.23B | |
+73.50% | 13.24B | |
+76.98% | 13.02B | |
-25.09% | 12.82B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating